According to the engineering report there are 17,000,000 metric tons of coal reserves on this property. The width of the property was measured at 238 meters by a length of 2150 meters, taking into consideration 20 layers with variable widths between 20 cm to 7 meters. With this method the reserves were calculated at 13,073,935 m3, equivalent to a total of 16,996,116 metric tons, assuming a density of 1.3 ton/m3. The full report is being translated and will be posted on the company's website.
For purposes of this evaluation, it is estimated that 70% of the reserves are exploitable. It is also estimated that the price for coal in the ground "in situ" is US $ 3/mt for thermal coal and US $ 9/mt for metallurgic or coking coal. According to this valuation method the gross value of the coal reserves while in the ground at La Tabaquera is US $ 70,230,085, taking into account 70% exploitation, the "in situ" value of the mine exceeds $ 49,000,000.
"Our team visited the mine on September 6th and 7th and identified other concessions in the area with potential sizable reserves that we intend to acquire from our major shareholder once the contract concessions are granted. They will add up to an additional 5000 ha with the probability of hundreds of millions of metric tons of high quality coal reserves," commented John Campo, President of VSUS Technologies Inc.
The Company President, John Campo, will be featured on the nationally syndicated radio program "Stu Taylor on Business" airing today September 20, 2011, at 11:30a.m. (EDT) on Money Matters Radio. The program can be heard live on WBNW-AM 1170, Boston's business and financial radio station, and over the Internet at www.moneymattersradio.net and www.livestream.com/wbnw1120. The program will be re-broadcast on the Business Talk Radio Network Wednesday September 21, 2011, at 1:30p.m. (EDT). All shows are archived and available on the Internet for four weeks following their original broadcast at www.businesstalkradio.net.
Transportation, Logistics and Other Information
VSUS Technologies is consulting to build or acquire wholly owned river loading facilities on the Magdalena River close to our mines. The coal will be trucked to these river ports, and then barged via the Magdalena River to the Ports of Barranquilla, Santa Marta, or Cartagena for export. The Company plans to build or acquire a river barge transportation company and an export coal terminal in Barranquilla, Colombia. Initially we will use existing facilities while our transportation projects are being developed. The Colombian and Chinese Governments are jointly improving railroads that will facilitate local coal producers' ability to export. After the rail projects and the "Road to the Sun" project are completed, VSUS Technologies will have one of the only coal mines in the World with river, rail, and road access to coal export terminals on both the Atlantic and Pacific Oceans.
About VSUS Technologies Inc.
VSUS Technologies is a growing company specializing in acquisitions of revenue generating businesses. The company has daily interactions with possible acquisition targets looking to expand our operations and the company revenue stream. We have recently signed an Agreement to acquire a mining concession by the name of La Tabaquera in Colombia. Over the past year the Company has continued to search for the right business plan and business model to add to the company's overall value. With core values of environmental and capital stewardship, we will strive to become good environmental neighbors and provide all shareholders operating and financial transparency. Our Company plans to have three revenue producing business units in Colombia: coking and coal mining, docks and river transportation along the Magdalena River, and a coal export terminal on the northern coast of Colombia. The Company is also exploring allegiances with U.S. universities to study capturing Coal Bed Methane (CBM) in Colombia. For more information on our company visit our new website at www.vsustechnologies.com.
Forward Looking Statements
Forward Looking Statements: This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," "intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations. VSUS Technologies Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
--------------------------------------------------------------------------------------
Caduceus Software Systems Corp. (CSOC) is a software company specializing in the development of an all-in-one solution for private practitioners and doctors with a focus in the healthcare information management industry. CSOC was created as the Company saw an urgent need for better patient care throughout the world. General practitioners are using unsophisticated software acts as more administrative than act as a time saving tool.
The Company’s flagship product is called Caduceus MMS version 1.0 — a sophisticated appointment scheduling and patient recording software system. It has the capability to add more functionality as needed by the doctors that use it.
Investment Highlights Shares of CSOC have gained 22.7% in the last five days; 3.9% in the last month; and 440.0% year to date. Shares of CSOC jumped 35% to close Monday’s session at $0.14. More than 21 million shares traded hands during the session, dwarfing the 10-day average of just 37.3K. Over the past 52-weeks, the stock has ranged from a low of $0.07 to a high of $0.18.
The Company early last month provided general information on its medical records management software (MMS). The Company said its software is targeted to provide Electronic Health Records management for practitioners and physicians, and combine it with the appointment scheduling tools useful for medical office assistants.
While some software caters to specifically to doctors and some software caters specifically to their supporting staff, CSOC said its Caduceus MMS integrates these tasks together in a single software solution. CSOC’s product also intends to reduce paperwork, which in turn reduces chance of key stroke input error as well as other forms of human error. “The recent news of the American health care reform and the cost of health care in Canada and United States warrant better software to manage the flow of patient information and fast and accurate billing,”
Derrick Gidden, president of CSOC stated in the press release.
Recognizing a huge market, Gidden said there are more than 800,000 private physicians and practitioners in North America that could benefit from CSOC’s software in terms of its price point, multiple languages, tech support, and platform compatibility requirements.
Source: http://finance.yahoo.com/news/Caduceus-Software-Systems-Inc-bw-1811410418.html?x=0&.v=1
Financial Summary CSOC has not earned any revenues since its inception and it does not anticipate earning revenues in the upcoming quarter. The Company reported net loss for the three month period ended June 30, 2011, of approximately $5.0 million, compared to a net loss of $4.8K during the three-month period ended June 30, 2010. During the three months ended June 30, 2011, the Company incurred general and administrative expenses of about $13.7K, compared to $4.6K incurred during the three month period ended June 30, 2010, an increase The general and administrative expenses incurred during the three month period ended June 30, 2011 consisted of legal, accounting and reporting requirements. Operating expenses for the three months ended June 30, 2011, increased by 297% as compared to the comparative period in 2010, primarily as a result of signing and closing a licensing agreement with Sygnit Corp. the exclusive license to software for use in the medical industry for patient management. CSOC anticipates continuing to rely on equity sales of its common stock in order to continue to fund its business operations. Issuances of additional shares will result in dilution to its existing stockholders. There is no assurance that it will achieve any additional sales of its equity securities or arrange for debt or other financing to fund its planned business activities. http://biz.yahoo.com/e/110822/csoc.ob10-q.html Comparative Analysis No direct competitor comparison. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them. Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing. Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
